Ep. 13 Percutaneous Tricuspid Interventions: Repair & Replacement Approaches with Dr. Joe Walsh and Dr. Aidan Raney

Tricuspid valve repair has seen booming growth in the interventional arena in the last five years, and the trajectory is only up from here. In this episode, interventional cardiologists Dr. Joe Walsh and Dr. Aiden Raney share their wealth of insights and experiences with the latest advancements in tricuspid interventions. --- SYNPOSIS The conversation covers recent landmark trials, relevant tricuspid physiology, and hands-on experiences in the cath lab with specialty devices like TriClip and Evoque. The interventionalists discuss patient selection, including how to distinguish which patients are most likely to benefit from intervention and how to define procedural success. Dr. Walsh and Dr. Raney also highlight the educational opportunities provided by MurmurMD, a specialized social media platform for peer-to-peer learning for cardiologists and cardiac surgeons. --- TIMESTAMPS 00:00 - Introduction01:29 - Tricuspid Valve Interventions: An Overview03:55 - Understanding Tricuspid Regurgitation10:29 - Therapeutic Options for the Tricuspid Valve29:25 - Evaluating Success Rates and Patient Expectations32:27 - Right Heart Catheterization33:04 - Patient Selection Criteria34:18 - Challenges with Tricuspid Valve Procedures34:31 - Case Study: Evoke Device Size Variation35:26 - Impact of Tricuspid Annulus Rigidity37:57 - Complications and Management in Tricuspid Procedures50:00 - Financial Considerations and Reimbursement54:17 - Training and Educational Resources59:49 - Conclusion and Final Thoughts --- RESOURCES Dr. Aidan Raneyhttps://www.providence.org/doctors/interventional-cardiology/az/phoenix/aidan-raney-1962631101 Dr. Joe Walshhttps://www.saintalphonsus.org/provider/joe-walsh Coapt Study https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2018/09/21/20/12/COAPT Triluminate Study:https://www.nejm.org/doi/full/10.1056/NEJMoa2300525 Triscend Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2401918

There are no comments yet.

Please log in to write the first comment.